Mobia Medical Announces Pricing of Initial Public Offering
HealthcareTexasOther
Mobia Medical
May 8, 2026
Cencora to Buy EyeSouth Retina Business for $1.1B
Announced
HealthcareDivestiture
Deal Overview
Cencora has agreed to acquire EyeSouth’s retina business from Olympus Partners for $1.1B. The transaction is structured as a divestiture of the retina-focused ophthalmology unit.
The deal sits in the ophthalmology segment of healthcare, where retina specialty services and products are typically bundled into focused business lines.
Key Details
- Transaction
- Cencora acquires EyeSouth Retina
- Deal Size
- Over $100M
- Reported Value
- $1.1B
Related Deals
Stryker completes acquisition of Amplitude Vascular Systems - MassDevice
HealthcareAdd-on
Stryker→Amplitude Vascular Systems
May 8, 2026
Odyssey, on second try, snags $279M in an IPO
HealthcareNew YorkOther
Odyssey Therapeutics
May 8, 2026
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
HealthcareMassachusettsOther
Odyssey Therapeutics
May 8, 2026
Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy
HealthcarePlatform
Angelini Pharma→Catalyst Pharmaceuticals
May 7, 2026